셀루메드
₩1,009
▲ +0.00
(+0.00%)
Volume: 0
· 2026-09-23
Loading…
RSI (14)
🧭 Style Verdicts
🚀
Momentum
50
- 21d momentum +0.0%
- RSI 100 overbought
🎯
Pullback
15
- +0.0% vs 20MA
💎
Value
39
- ROE -7.2%
- Op. margin -6.7%
Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.
📐 Technicals
RSI(14)100.0
MACD+0.000
MA trendMixed
ATR100.00%
21d mom.+0.0%
63d mom.+0.0%
vs 20MA+0.0%
RVOL(20)—
52w low
52w high
Computed live from daily OHLCV · as of 2026-09-23
🏦 Fundamentals
ROE-7.2%
Op. margin-6.7%
Net margin-7.3%
FY2026
| Year | Revenue | Op. income | Op. margin |
|---|---|---|---|
| 2023 | 0.1T | -0.0T | -10.9% |
| 2024 | 0.1T | -0.0T | -5.3% |
| 2025 | 0.1T | -0.0T | -3.7% |
| 2026 | 0.0T | -0.0T | -6.7% |
From DART financial statements (KRW). Annual (or latest reported quarter).
⚖️ AI Bull vs Bear
14d momentum +0.00%, daily vol 0.00%. 셀루메드 sits in a mixed regime.
Derived from 14-day momentum and daily volatility on real OHLCV.
🗞 Related News
No recent news.
🏦 Investor Flow
Foreign
+0억
Institution
+0억
Retail
-0억
| Date | Foreign | Inst. | Retail |
|---|---|---|---|
| 09-30 | +0 | +0 | -0 |
| 09-29 | +0 | +0 | -0 |
| 09-26 | -0 | +0 | +0 |
| 09-25 | +0 | +0 | +-0 |
| 09-24 | +0 | +0 | -0 |
Net buy/sell in ₩100M (억). Positive = net buying.